Ultram For Fibromyalgia
Use Ultram for Fibromyalgia Fro Pain Management.
The German pharmaceutical company, Grunenthal GmbH, first presented the drug Ultram as Tramal and still holds the patent to the drug. The company has cross-licensed Tramal, allowing the United States to market Tramal under the name Ultram. Ultram was first introduced to the US market and used to treat the symptoms of fibromyalgia in 1970.
People who suffer from fibromyalgia experience wide-spread pain that affects their daily life and ability to perform in the workplace.
Ultram, available in 50 mg tablets, is a medication geared toward moderate to severely moderate pain and is used to ease the debilitating symptoms of fibromyalgia. Pain management increases the ability to perform more normal daily tasks that may otherwise be too painful to handle.
There are other forms of Ultram available on the pharmaceutical market. Ultram also comes in a once daily tablet called Ultram ER (Extended-Release). Ultram ER is available in 100 mg, 200 mg and 300 mg dosages. Both Ultram and Ultram ER are helpful in relieving muscle pain in people who suffer from fibromyalgia.
As of yet, no other drug companies have the rights to manufacture Ultram or Ultram ER in the treatment of pain associated with fibromyalgia. Ortho-McNeil has the patent for Ultram, which will not run out until May, 2014.
At that time, Tramadol, or Ultram, will most likely be offered by other pharmaceutical companies.
Tramadol is not the generic version of Ultram, it is only the active ingredient found in Ultram. Some of the side affects of using Ultram may include dizziness, nausea, constipation or sweating. You should not operate heavy machinery or drink alcohol while taking Ultram to ease the symptoms of fibromyalgia. If you are, or think you may be, pregnant, consult your doctor before beginning any medication. Always consult your doctor before beginning any new medication.